Last reviewed · How we verify
Diuretics
At a glance
| Generic name | Diuretics |
|---|---|
| Also known as | Chlorthalidone/Amiloride, Diuretic therapy, hydrochlorothiazide, bumetanide, furosemide |
| Sponsor | Hospital de Clinicas de Porto Alegre |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES) (NA)
- Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure (NA)
- Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure (NA)
- Forebrain Electroneutral Transporters in Salt-sensitive Hypertension: an MRI Study (PHASE4)
- ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure (NA)
- Venous Congestion And Cognitive Dysfunction After Cardiac Surgery
- Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure (PHASE4)
- Hemodynamic Resuscitation Guided by Non-Invasive Mean Systemic Filling Pressure to Prevent Acute Kidney Injury in Septic Shock (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diuretics CI brief — competitive landscape report
- Diuretics updates RSS · CI watch RSS
- Hospital de Clinicas de Porto Alegre portfolio CI